****

The annual meeting of the American Society of Oncology (ASCO) brought together experts and enthusiasts for a deep dive into the latest developments in cancer research and treatment. Among the attendees were key voices in the biotech sector, including senior writer Adam Feuerstein and journalist Angus Chen from STAT.

Adam Feuerstein, known for his in-depth analysis at the junction of drug development, business, and biotechnology, kept the audience engaged with his expertise. Feuerstein is also the co-host of "The Readout Loud," a weekly biotech podcast, and the author of "Adam's Biotech Scorecard." He invited attendees to connect with him on Signal at stataf.54 for further insights.

Angus Chen, who focuses on a wide range of cancer-related issues including drugs, policy, science, and equity, shared notable perspectives gained from his extensive experience at NPR and NPR affiliate stations. Chen, who joined STAT in 2021, has earned accolades such as the national Edward R. Murrow awards and the June L. Biedler prize for cancer journalism. Chen can be reached on Signal at angus.08.

For those who couldn't attend the in-person STAT@ASCO event, a virtual STAT Recap event was announced, which promises to deliver highlights and key takeaways from the conference. It is scheduled for Wednesday and is still open for registration. This newsletter is part of STAT’s special coverage from ASCO, providing exclusive information for STAT+ subscribers who can access daily analyses and updates in the biotech sector.

The meeting underscored the significant strides being made in oncology, demonstrating the importance of staying informed on the cutting-edge research and policies shaping the future of cancer treatment.